B Möller

Sorbonne Université — France

Medicine · Health Sciences

13h-index887citations88works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatitis C virus research(51), Hepatitis B Virus Studies(24), Liver Disease Diagnosis and Treatment(24), Immunodeficiency and Autoimmune Disorders(19), Diabetes and associated disorders(11)

Publications88 total

797 HIGH PREVALENCE OF CHRONIC HEPATITIS C IN 8009 PATIENTS WITH MIGRATION BACKGROUND LIVING IN GERMANY
Journal of Hepatology·2013· 2 cited
912 LEUKOCYTE DECLINE PREDICTS SUSTAINED VIROLOGIC RESPONSE IN PATIENTS UNDERGOING PEGINTERFERON alfa-2b/RIBAVIRIN TREATMENT OF CHRONIC HCV GENOTYPE 1 INFECTION
Journal of Hepatology·2013
Effects of pre-treatment with bezafibrate followed by standard of care in treatment-naive patients with chronic hepatitis C genotype 1 infection and elevated GGT levels
Zeitschrift für Gastroenterologie·2012
1164 HEMOGLOBINE DECLINE DURING PEGINTERFERON ALFA-2B/RIBAVIRIN TREATMENT IN REAL-LIFE IS ASSOCIATED WITH FAVORABLE SVR RATES IN DIFFICULT-TO-TREAT PATIENTS WITH HCV GENOTYPE 1 INFECTION
Journal of Hepatology·2012· 1 cited
Evaluation of a rapid on-site anti-HCV test as screening tool for hepatitis C infection
Zeitschrift für Gastroenterologie·2012
Die Bedeutung verschiedener sensitiver HCV RNA-Assays für die Response- gesteuerte Therapie bei Patienten mit chronischer Hepatitis C
Zeitschrift für Gastroenterologie·2011
Die Relapse-Rate korreliert mit dem virologischen Ansprechen zu Woche 4 und 12 unter PEG-Interferon/Ribavirin, jedoch nicht mit dem IL28B Genotyp bei Patienten mit chronischer HCV Typ 1-Infektion
Zeitschrift für Gastroenterologie·2011
Wirtsspezifische Response-Marker unabhängig vom IL-28B-Genotyp für das Ansprechen auf eine individualisierte Therapie bei Patienten mit chronischer HCV Typ 1- Infektion
Zeitschrift für Gastroenterologie·2011
483 IMPORTANCE OF HCV RNA ASSAY CHARACTERISTICS AND DIFFERENCES BETWEEN ASSAYS FOR RESPONSE GUIDED THERAPY OF CHRONIC HEPATITIS C
Journal of Hepatology·2011
1349 VIROLOGIC RELAPSE IS HIGHLY CORRELATED WITH RESPONSE AT WEEK 4 AND 12 BUT NOT WITH IL28B GENOTYPE IN HCV GENOTYPE 1-INFECTED PATIENTS TREATED WITH PEG-INTERFERON/RIBAVIRIN
Journal of Hepatology·2011
1351 PREDICTION OF RELAPSE AFTER PEGINTERFERON ALFA-2B/RIBAVIRIN THERAPY IN CHRONIC HCV GENOTYPE 1 PATIENTS IS DEPENDENT ON MINIMAL RESIDUAL VIREMIA BUT NOT ON IL28B GENOTYPE
Journal of Hepatology·2011· 1 cited
404 DOSE REDUCTION OF PEGINTERFERON ALFA-2A (PEG) IN COMBINATION WITH RIBAVIRIN (RBV) IN CHRONIC HEPATITIS C (CHC) PATIENTS: IMPACT ON VIROLOGICAL RESPONSE UNDER REAL LIFE CONDITIONS
Journal of Hepatology·2011
435 TREATMENT OF HCV GENOTYPE 3 (GT3)-INFECTION WITH PEG-IFN A-2B AND RIBAVIRIN (RBV): AGE RELATED DIFFERENCES IN SVR AND RELAPSE
Journal of Hepatology·2011Open Access
1350 HOST-SPECIFIC FACTORS INDEPENDENT OF IL28B GENOTYPE PREDICTING TREATMENT OUTCOME OF INDIVIDUALIZED THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE 1 INFECTION
Journal of Hepatology·2011Open Access
447 DIFFERENCES IN DEMOGRAPHICS AND TREATMENT OUTCOME OF CHRONIC HEPATITIS C (CHC) PATIENTS OF DIFFERENT EUROPEAN ORIGIN TREATED WITH PEGINTERFERON ALFA-2A (40KDA) AND RIBAVIRIN (PEG/RBV)
Journal of Hepatology·2011· 1 cited
CD154, a marker of antigen‐specific stimulation of CD4 T cells, is associated with response to treatment in patients with chronic HCV infection
Journal of Viral Hepatitis·2011· 21 cited
Treatment of chronic hepatitis C with PegIFN-alfa2b and ribavirin: Outcome for migrants from GUS countries is associated with higher SVR-rates compared to German patients within a large German multicentric observational study
Zeitschrift für Gastroenterologie·2010
Hämoglobinabfall in Assoziation zu RBV Dosierung und SVR bei HCV GT-1 infizierten Patienten, die mit PEGINTERFERON ALFA-2A/RIBAVIRIN (PEG/RBV) unter Alltagsbedingungen behandelt wurden: Neue Aspekte?
Zeitschrift für Gastroenterologie·2010
Klinische Marker des metabolischen Syndroms sind häufiger mit HCV Genotyp 1 Infektion assoziiert und sind starke negative Prädiktoren für eine EVR
Zeitschrift für Gastroenterologie·2010
Improvement of sustained virologic response (SVR) in the treatment of genotype 1 infected male patients with PEG-INFα-2b by ribavirin dose adjustments
Zeitschrift für Gastroenterologie·2010
page 1 of 5Next →

Frequent Co-authors

U. Hopf(12), H. Lobeck(9), Thomas Berg(9), Peter Buggisch(8), G Teuber(8), U. Alshüth(6), R Heyne(6), C. Sarrazin(6), Hartwig Klinker(6), Stefan Zeuzem(6), D Hüppe(5), E Zehnter(5), Bernd Bokemeyer(5), Tracey Lutz(4), C John(4), U Hopf(4), Nektarios Dikopoulos(4), Jens Encke(4), V Weich(4), R. Stemerowicz(3)